Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
Actual shortage: | 243 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223058 |
APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223055 |
APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223052 |
APO-PROPAFENONE | 150MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223049 |
APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-03-22 | 2024-04-05 | 223046 |
APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223043 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2024-03-15 | 2024-05-03 | 222481 |
APO-NAPROXEN | 500MG | TABLET | Actual shortage | 2024-03-15 | 2024-04-05 | 222478 |
ANAFRANIL | 25MG | TABLET | Resolved | 2024-03-15 | 2024-03-22 | 222473 |
APO-IBUPROFEN | 400MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222470 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2024-03-15 | 2024-03-22 | 222467 |
APO-SUMATRIPTAN | 50MG | TABLET | Resolved | 2024-03-15 | 2024-04-19 | 222464 |
HEARTBURN CONTROL | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-03-15 | 2024-04-05 | 222461 |
APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222458 |
APO-BACLOFEN | 20MG | TABLET | Actual shortage | 2024-03-15 | 2024-05-03 | 222455 |
APO-DOXY CAP 100MG | 100MG | CAPSULE | Resolved | 2024-03-15 | 2024-04-05 | 222414 |
APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221732 |
APO-RIVASTIGMINE | 1.5MG | CAPSULE | Actual shortage | 2024-03-08 | 2024-03-22 | 221729 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2024-03-08 | 2024-04-19 | 221726 |
APO-METHYLPHENIDATE | 5MG | TABLET | Actual shortage | 2024-03-08 | 2024-05-03 | 221723 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |